Stocktoria
BIOMERICA INC BMRA
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1980-03-17
BIOMERICA INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.3M | $5.4M | $5.3M | $18.9M | $7.2M |
| Gross profit | $498,000 | $611,000 | $446,000 | $3.0M | $366,285 |
| R&D expense | $1.0M | $1.5M | $1.6M | $1.8M | $2.2M |
| SG&A expense | $4.6M | $5.5M | $6.1M | $5.7M | $5.7M |
| Operating income | -$5.1M | -$6.4M | -$7.2M | -$4.5M | -$7.5M |
| Interest expense | — | — | — | — | $367 |
| Income tax | $1,000 | $42,000 | $51,000 | $24,000 | $13,057 |
| Net income | -$5.0M | -$6.0M | -$7.1M | -$4.5M | -$7.4M |
| EPS (diluted) | $-2.16 | $-2.84 | $-0.50 | $-0.36 | $-0.62 |
| Operating cash flow | -$3.8M | -$5.4M | -$5.5M | -$479,000 | -$5.3M |
| Free cash flow | — | -$5.4M | -$5.5M | -$536,000 | -$5.4M |
| Cash & equivalents | $3.1M | $4.2M | $9.7M | $5.9M | $4.2M |
| Inventory | $1.5M | $2.4M | $2.1M | $2.4M | $3.2M |
| Total assets | $5.9M | $9.3M | $14.5M | $11.4M | $11.8M |
| Total liabilities | $1.8M | $2.7M | $2.7M | $3.0M | $2.6M |
| Shareholders' equity | $4.1M | $6.6M | $11.7M | $8.3M | $9.2M |
Source: SEC EDGAR filings · CIK 0000073290 · as of 2025-05-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.